Publications by authors named "Larry Danziger"

Claim this Profile
P
Pharmacokinetic drug evaluation of co-packaged sulbactam for injection and durlobactam for injection for the treatment of complex in HABP/VABP.
Rodrigo M Burgos, Yifan Wang, Jysheng Hou, Larry H Danziger

Expert Opin Drug Metab Toxicol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of rehospitalization due to infection among hospitalized patients with : a cohort study.
Emily N Drwiega, Stuart Johnson, Larry H Danziger, Andrew M Skinner

Infect Control Hosp Epidemiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of fecal microbiota, live-jslm for the prevention of recurrent Clostridioides difficile infection.
Aaron Hunt, Emily Drwiega, Yifan Wang, Larry Danziger

Am J Health Syst Pharm· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commonly Reported Mosquito-Borne Viruses in the United States: A Primer for Pharmacists.
Emily N Drwiega, Larry H Danziger, Rodrigo M Burgos, Sarah M Michienzi

J Pharm Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent Infection.
Yifan Wang, Aaron Hunt, Larry Danziger, Emily N Drwiega

Antibiotics (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and Outcomes of Patients at a Specialty Clinic for Infection.
Aaron Hunt, Larry H Danziger, Stuart Johnson, Andrew M Skinner

Open Forum Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic evaluation of cefiderocol for the treatment of multidrug resistant Gram-negative infections.
Emily N Drwiega, Nicole C Griffith, Larry H Danziger

Expert Opin Drug Metab Toxicol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences.
Andrew M Skinner, Xing Tan, Benjamin D Sirbu, Larry H Danziger, Dale N Gerding

Clin Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance data.
David A Butler, Mark Biagi, Vikas Gupta, Sarah Wieczorkiewicz, Lisa Young, Larry Danziger

Infect Control Hosp Epidemiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Urinary Tract Infections and Possible Treatment.
Nicole Griffith, Larry Danziger

Antibiotics (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent Clostridioides difficile Infections: Should We Respond More to Toxin B?
Christopher A Schriever, Larry H Danziger

Clin Infect Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model.
Kevin A Meyer, Matthew F Deraedt, Amanda T Harrington, Larry H Danziger, Eric Wenzler

Int J Antimicrob Agents· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candidemia Secondary to Chronic Candiduria.
Mark J Biagi, Nathan P Wiederhold, Connie Gibas, Brian L Wickes, Victoria Lozano, Larry Danziger

Open Forum Infect Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic evaluation of meropenem and vaborbactam for the treatment of urinary tract infection.
Rodrigo M Burgos, Mark J Biagi, Keith A Rodvold, Larry H Danziger

Expert Opin Drug Metab Toxicol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.
Eric Wenzler, Susan C Bleasdale, Monica Sikka, Kristen L Bunnell, Matthew Finnemeyer, Larry H Danziger

Antimicrob Agents Chemother· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use of the polymyxins: the tale of the fox and the cat.
Eric Wenzler, Kristen L Bunnell, Larry H Danziger

Int J Antimicrob Agents· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult Subjects.
Kristen L Bunnell, Manjunath P Pai, Monica Sikka, Susan C Bleasdale, Eric Wenzler, Larry H Danziger

Antimicrob Agents Chemother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae.
Kristen L Bunnell, Eric Wenzler, Amanda T Harrington, Larry H Danziger

Diagn Microbiol Infect Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile.
Margaret M Guinta, Kristen Bunnell, Amanda Harrington, Susan Bleasdale, Larry Danziger

Ann Clin Microbiol Antimicrob· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration.
Eric Wenzler, Kristen L Bunnell, Susan C Bleasdale, Scott Benken, Larry H Danziger

Antimicrob Agents Chemother· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA.
Karolyn S Horn, Larry H Danziger, Keith A Rodvold, Robert C Glowacki

Expert Opin Drug Metab Toxicol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Barriers in the Treatment of Infection With Oral Vancomycin.
Kristen L Bunnell, Larry H Danziger, Stuart Johnson

Open Forum Infect Dis· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
Kevin Meyer, Maressa Santarossa, Larry H Danziger, Eric Wenzler

Hosp Pharm· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile.
Kevin W McConeghy, Melinda M Soriano, Larry H Danziger

Pharmacotherapy· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled Antibiotics for Gram-Negative Respiratory Infections.
Eric Wenzler, Dustin R Fraidenburg, Tonya Scardina, Larry H Danziger

Clin Microbiol Rev· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis